Protection of epithelial cells from Salmonella enterica serovar Enteritidis invasion by antibodies against the SPI-1 type III secretion system

Canadian Journal of Microbiology
Taseen S DesinWolfgang Köster

Abstract

Salmonella enterica serovar Enteritidis (Salmonella Enteritidis) is one of the major causes of bacterial food-borne illness in humans. During the course of infection, Salmonella Enteritidis uses 2 type III secretion systems (T3SS), one of which is encoded on Salmonella pathogenicity island 1 (SPI-1). SPI-1 plays a major role in the invasion process. In the present study, we evaluated the effect of sera against the SPI-1 T3SS components on invasion in vitro using polarized human intestinal epithelial cells (Caco-2). Antisera to SipD protected Caco-2 cells against entry of wild-type Salmonella Enteritidis. On the other hand, sera against InvG, PrgI, SipA, SipC, SopB, SopE, and SopE2 did not affect Salmonella Enteritidis entry. To illustrate the specificity of anti-SipD mediated inhibition, SipD-specific antibodies were depleted from the serum. Antiserum depleted of SipD-specific antibodies lost its capacity to inhibit Salmonella Enteritidis entry. Thus, we demonstrate for the first time that antibodies against the SPI-1 needle tip protein (SipD) inhibit Salmonella Enteritidis invasion and that the SipD protein may be an important target in blocking SPI-1 mediated virulence of Salmonella Enteritidis.

References

Nov 1, 1990·The Journal of Infectious Diseases·B B Finlay, S Falkow
Sep 1, 1994·Gastroenterology·B F King
Apr 1, 2000·Microbes and Infection·S L MarcusB B Finlay
Feb 8, 2005·Current Opinion in Microbiology·Jayesh C Patel, Jorge E Galán
Jan 13, 2006·Current Opinion in Microbiology·Markus C Schlumberger, Wolf-Dietrich Hardt
Feb 24, 2006·Nature Reviews. Immunology·Marian R Neutra, Pamela A Kozlowski
Nov 23, 2006·Microbes and Infection·Filip BoyenFreddy Haesebrouck
Mar 17, 2007·Avian Pathology : Journal of the W.V.P.A·P A Barrow
Nov 21, 2007·Nature Reviews. Microbiology·Andrea HaragaSamuel I Miller
Aug 2, 2008·Cellular Microbiology·Roman G GerlachMichael Hensel
Dec 3, 2008·Applied and Environmental Microbiology·Yukiko Toyota-HanataniEiichiroh Baba
Jan 23, 2009·Current Opinion in Microbiology·Emma J McGhieVassilis Koronakis

❮ Previous
Next ❯

Citations

Feb 2, 2013·Current Microbiology·Fengxia QueRui Huang
Dec 4, 2013·Microbiology and Molecular Biology Reviews : MMBR·Steven L FoleyJessica Danzeisen
Aug 21, 2019·Frontiers in Cellular and Infection Microbiology·Lixin LouYang Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.